PRINTER'S NO. 3183
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No.
2147
Session of
2018
INTRODUCED BY SANTORA, C. QUINN, BARRAR, READSHAW, DRISCOLL,
BERNSTINE, TOOHIL, SAYLOR, MURT, DeLUCA, TOEPEL, HILL-EVANS,
DOWLING, STAATS AND M. QUINN, MARCH 16, 2018
REFERRED TO COMMITTEE ON JUDICIARY, MARCH 16, 2018
AN ACT
Amending the act of April 14, 1972 (P.L.233, No.64), entitled
"An act relating to the manufacture, sale and possession of
controlled substances, other drugs, devices and cosmetics;
conferring powers on the courts and the secretary and
Department of Health, and a newly created Pennsylvania Drug,
Device and Cosmetic Board; establishing schedules of
controlled substances; providing penalties; requiring
registration of persons engaged in the drug trade and for the
revocation or suspension of certain licenses and
registrations; and repealing an act," further providing for
drug overdose response immunity.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Section 13.7(c) of the act of April 14, 1972
(P.L.233, No.64), known as The Controlled Substance, Drug,
Device and Cosmetic Act, is amended to read:
Section 13.7. Drug Overdose Response Immunity.--* * *
(c) [Persons experiencing drug overdose events may not be
charged and shall be immune from prosecution as provided in
subsection (b) if a person who transported or reported and
remained with them may not be charged and is entitled to
immunity under this section.] (1) A person experiencing a drug
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
overdose event may not be charged and shall be immune from
prosecution if, within ten days after receiving medical
attention for the drug overdose event, the person experiencing
the drug overdose event obtained a screening and received a
referral for treatment from a properly accredited addiction
services provider, including a certified recovery specialist or
other trained medical professional.
(2) A person who transported or reported and remained with a
person experiencing a drug overdose event may not be charged and
is entitled to immunity under this section.
* * *
Section 2. This act shall take effect in 60 days.
20180HB2147PN3183 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12